Lv2
160 积分 2024-10-23 加入
Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling
1天前
待确认
Development of RMC-6236, a potent and orally bioavailable RAS(ON) multi-selective tri-complex inhibitor for the treatment of RAS-addicted cancers by targeting multiple RAS variants
10天前
已完结
Pan-cancer analysis of oncogenic MET fusions reveals distinct pathogenomic subsets with differential sensitivity to MET-targeted therapy
10天前
已完结
CellofOriginInfluencesPancreaticCancerSubtype
23天前
已完结
Cell of Origin Influences Pancreatic Cancer Subtype
1个月前
已完结
Cell of Origin Influences Pancreatic Cancer Subtype
1个月前
已完结
Novel insights into the dynamic function of PRC2 in innate immunity
1个月前
已完结
Response and Resistance to RAS Inhibition in Cancer
1个月前
已完结
Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of Diffuse Large B-cell Lymphoma
1个月前
已关闭
Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer
1个月前
已完结
皖公网安备34019202002308
